Refractive surgery growth slowdown
Refractive surgeries grew only 3% YoY in Q1, attributed to seasonality and lack of promotional push. Full-year growth may not match overall surgery growth if demand does not pick up in Q2/Q3.
AGARWALEYE / bear-case history
Track the concerns that keep returning.
Dr. Agarwal's Health Care · risk themes across the available quarters.
Research layer active
Bear-case history
Risks carried through the record.
medium
Delhi NCR expansion execution risk
The new Delhi facility faced a 6-9 month delay due to floods. While now operational, scaling up in a competitive market may take time and could impact near-term profitability.
Subsidiary merger timeline uncertainty
Management provided a broad timeline of 1-1.5 years for the merger but noted it is still under evaluation. Delays could affect corporate structure and minority shareholder returns.
Geopolitical disruption impact
Operations in northern India were briefly impacted by the Bahalgam attack and Operation Hindu, highlighting vulnerability to regional disruptions.
Slower ramp-up in new geographies
New facilities in non-core markets like Delhi and Ethiopia may take 15-18 months to break even, potentially pressuring near-term margins.
Refractive surgery slowdown
Refractive surgery volumes were slower this year due to industry-wide softness, which could persist and impact growth.
Revenue per facility decline in newer regions
Analyst noted a drop in revenue per facility in the east region; management attributed it to early-stage facilities, but sustained underperformance could signal competitive pressure.
Labor code implementation risk
New labor codes could increase employee costs; management assessed impact as not material currently but continues to monitor.